Continued Strong Growth Expected for OxySure
OxySure Systems (OTCQB: OXYS), the medical device innovator of life-saving easy-to-use emergency oxygen solutions and other medical technologies, was recently ranked as one of the top five fastest growing technology companies in North Texas. Its staggering growth of 801% between 2012 and 2014 earned OXYS the number four spot at the Metroplex Technology Business Council’s Tech Titan Awards Gala in August, and with multiple major milestones achieved in 2015, we believe this microcap stock is poised to continue its track record of growth.
The Company’s growth has been primarily fueled by the success of its unique oxygen from powder technology, the OxySure Model 615. With the Model 615, there are no compressed tanks, no dials, no valves, no regulatory maintenance, no hydrostatic testing, no batteries, and no required training, and the technology is both safe and easy-to-use for the layperson.
Similar to an automated external defibrillator (AED) or fire extinguisher, the Model 615 can be placed just about anywhere a medical emergency might occur to help improve medical outcomes and save lives by bridging the gap between a medical emergency and the arrival of first responders on the scene.
The Journal of Emergency Medical Services (JEMS) recently published an opinion paper that paves the way for wider adoption of “public/first aid oxygen” usage, such as the Model 615.
Commenting on the paper, Julian Ross, CEO of OXYS, stated, "We have always believed that to improve medical outcomes the significant risks associated with hypoxia in a medical emergency have to be addressed as soon as possible after its onset. The JEMS opinion lays to rest any concerns about "over-oxygenation" in certain situations, and provides EMS and lay rescuers peace of mind regarding the use of FDA-approved first aid oxygen units on an emergency basis prior to the availability of pulse oximetry (usually upon the arrival on the scene of trained first responders)."
Over the summer, the Model 615 portable emergency oxygen device was used 18 times during the Special Olympics World Games in Los Angeles.
"We feel honored to have played a role in providing a safety net and serving the medical emergency needs of the Special Olympics World Games," said Ross. "And knowing that our product was successfully used in 18 saves makes it that much more meaningful."
Increasing interest in the Model 615 has spurred OXYS to expand its sales team, and in early September, the Company announced the appointment of two new Territory Sales Managers in Indiana and Colorado. These new additions add to a growing nationwide direct sales team that complements and enhances the Company’s existing distribution sales channel, comprising in excess of fifty distribution partners.
With so many great things happening for this undervalued microcap stock, OXYS recently announced that its stockholders voted to approve two proposals designed to support an uplisting of the Company to a national exchange such as NASDAQ. The increased visibility that comes with a major exchange listing would likely lead to much higher share prices.
Independent equity research firm SeeThruEquity has a price target of $2.30 on OXYS, calling the Company "an intriguing speculative medical device company entering what should be a significant growth year, with an innovative product targeting a large potential market."
RedChip analysts concur and currently have a price target of $1.90 on OXYS. From its recent price of just $0.28 per share, this represents significant upside for investors. Learn more about OXYS today by visiting their stock page where you can download our latest research profile, watch interviews with management, and more.
Disclosure: RedChip Companies, Inc. research reports, company profiles and other investor relations materials, publications or presentations, including web content, are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in RedChip reports, company profiles, or other investor relations materials and presentations are subject to change. RedChip Companies and its affiliates may buy and sell shares of securities or options of the issuers mentioned on this website at any time. The information contained herein is not intended to be used as the basis for investment decisions and should not be construed as advice intended to meet the particular investment needs of any investor. The information contained herein is not a representation or warranty and is not an offer or solicitation of an offer to buy or sell any security. To the fullest extent of the law, RedChip Companies, Inc., our specialists, advisors, and partners will not be liable to any person or entity for the quality, accuracy, completeness, reliability or timeliness of the information provided, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information provided to any person or entity (including but not limited to lost profits, loss of opportunities, trading losses and damages that may result from any inaccuracy or incompleteness of this information). Stock market investing is inherently risky. RedChip Companies is not responsible for any gains or losses that result from the opinions expressed on this website, in its research reports, company profiles or in other investor relations materials or presentations that it publishes electronically or in print. We strongly encourage all investors to conduct their own research before making any investment decision. For more information on stock market investing, visit the Securities and Exchange Commission ("SEC") at www.sec.gov. OXYS agreed to pay RedChip a monthly cash fee and 250,000 warrants with a conversion price of $1.20 and a term of five (5) years for twelve (12) months of service. Investor awareness services and programs are designed to help small-cap companies communicate their investment characteristics. RedChip investor awareness services include the preparation of a research profile(s), multimedia marketing, and other awareness services.